Activating mutations in NOTCH1 have also been identified in chronic lymphocytic leukemia, non-small cell lung carcinoma, and translocations involving NOTCH1/2 in patients with triple negative breast cancer (10–13). Here, NOTCH1 is linked to triple-negative breast carcinoma.